Abstract
Aerobic training is popular for people with Parkinson’s disease (PD) given its potential to improve aerobic capacity, relieve symptoms, and to stabilise disease progression. Although current evidence supports some of the assertions surrounding this view, the effect of exercise intensity on PD is currently unclear. Reasons for this include inconsistent reporting of exercise intensity, training regimes based on general guidelines rather than individualised physiological markers, poor correspondence between intended exercise intensities and training zones, and lack of awareness of autonomic disturbance in PD and its impact on training regimes and outcome. We also consider the selective effect of exercise intensity on motor symptoms, function and disease progression. We review aerobic training protocols and recent guidelines for people with PD, highlighting their limitations. Considering this, we make suggestions for a more selective and discerning approach to aerobic training programming.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Physical exercise is critical to the management of Parkinson’s disease (PD) and is tailored according to individual needs as the disease progresses [1, 2]. The overarching goal of exercise is to enhance physical performance, health and wellbeing through an incremental increase in energy expenditure [3, 4]; a goal that in recent years has focused on the selective and critical role of aerobic training as a popular form of exercise in PD with trials evaluating its impact [5, 6]. There is also evidence to suggest that aerobic training at higher intensities may afford neuroprotection through stabilising motor symptoms and delaying disease progression. Although this theory is mainly supported by animal models, recent and ongoing studies suggest the evidence base is starting to expand [6,7,8,9].
Recent reviews report a positive effect of aerobic training on PD [10,11,12,13]. Less well understood is the specific effect of level of intensity on aerobic performance, motor symptoms and function, and whether protocols could be targeted more effectively to improve outcomes. Protocols very often follow training zones from general guidelines (e.g., American College of Sports Medicine (ACSM)) that do not take into account individualised responses to training regimes [14, 15]. These guidelines incorporate exercise intensity thresholds based on a percentage of maximal physiological measures such as maximum heart rate (%HRmax) and heart rate reserve (%HRR), obtained from maximum exercise tests or age-predicted equations. Subjective measures of intensity (e.g., rating of perceived exertion (RPE) scale) are also used [4]. A second issue is that the level of exercise intensity actually attained during aerobic training does not always align with the intended training zone which is particularly relevant if autonomic dysfunction is present given that it alters the assessment of metabolic and cardiac function [16, 17]. Finally, aerobic protocols often lack clarity around specific goals of training.
The aim of this review is to appraise exercise intensity as a key component of aerobic training with respect to aerobic capacity, functional performance, and motor symptoms in PD. We identify challenges associated with the implementation of high-intensity training and address the potential impact of impaired heart rate (HR) response on exercise intensity prescription. We limit our review to aerobic training protocols using cardiopulmonary exercise testing (CPET) to evaluate changes in aerobic capacity, due to its precision in capturing the physiological response to incremental exercise.
Method
The search strategy for this narrative review was not systematic, given the nature of the narrative approach. We conducted searches on the following databases: Scopus, Medline via EBSCO, and Google Scholar. The key search terms used were Parkinson’s disease, aerobic exercise, aerobic training, aerobic capacity, peak and maximum oxygen consumption (VO2peak and VO2max), cardiopulmonary exercise testing (CPET), graded exercise test, blunted heart rate (HR), impaired autonomic nervous system, chronotropic incompetence (CI), and dysautonomia. We also checked all references of the papers we cited to ensure we had optimal coverage of the literature. We limited our review to aerobic training protocols that have used CPET to evaluate changes in aerobic capacity. In our search, we did not identify any articles evaluating HR responses in people with PD with CI. Therefore, unpublished CPET data conducted in our lab from 13 PD subjects with and 15 without CI were used to highlight the differences in HR responses and attained training zones between these two groups.
Terminology and scope of the review
We define exercise intensity as the amount of physical effort, quantified as a percentage of an individual’s maximal physiological and clinical response to exercise [3, 18]. Training volume is defined as the product of duration (time per session) and frequency of training per week [18]. For consistency we use the term peak oxygen consumption (VO2peak) to represent the highest value attained during CPET to describe maximum aerobic capacity, instead of maximum oxygen consumption (VO2max) which requires a physiological response known as a plateau that proves challenging to be elicited within a clinical population [4, 19]. Whilst training volume and exercise modality are both important features of aerobic training, we do not consider them in detail in this review. However, we do comment on their application and efficacy where relevant.
Classification of exercise intensity and training zones
Studies evaluating the impact of exercise intensity in PD commonly apply aerobic protocols that reflect the ACSM five training zones classification [14, 20,21,22]. These training zones (Table 1) are typically defined as a percentage of maximal physiological or clinical measures of exercise intensity and vary from very light to near maximal intensity [4]. The term ‘high intensity training zone’ is frequently reported in the literature but not included in the ACSM classification. However, there is general agreement that high-intensity aerobic training elicits exercise intensities above 85% HRmax, 85% VO2peak, or 80% HRR [23,24,25,26] which approximate the higher end of the ‘vigorous’ and ‘near maximal’ training zones from the ACSM classification.
A second approach to classifying exercise intensity is the threshold zone classification, which is based on personalized physiological measures (first (VT1) and second (VT2) ventilatory thresholds) obtained from CPET [27, 28]. One advantage of the threshold zone classification over the ACSM classification is that it provides a comparable level of metabolic stimulus needed for a training effect across a population that vary in fitness levels [15]. In the threshold zone classification, light intensity reflects workload and physiological measures (e.g., HR, oxygen consumption) below VT1, whereas moderate intensity represents these measures between VT1 and VT2, and high intensity above VT2 [29,30,31,32]. The threshold zone classification may reproduce a more individualised and accurate classification of exercise intensity compared to the five training zones [27, 28].
Studies show that aerobic training protocols based on the threshold zone classification yield greater improvements in VO2 peak compared with protocols that use %HRmax or %HRR, suggesting it is a more responsive metric [15, 33,34,35]. A study by Weatherwax et al., [33] illustrates this point. They found that 100% of healthy individuals aged between 30 and 75 year who used a threshold zone for training were classified as positive responders (change in VO2peak > 4.7%). By contrast, only 60% of those in the control group, who trained based on %HRR, were classified as positive responders. Although the threshold zone is widely applied in sports performance [18, 36] and more recently in cardiac rehabilitation [28, 37], the aerobic training protocols included in this review (Table 2) do not use VT1 and VT2 to prescribe exercise intensity despite using CPET to measure aerobic capacity. Instead, the percentage of maximum values of physiological measures (e.g., %HRmax and %VO2peak) obtained from CPET or age-predicted equations are used. There are arguments for and against the different approaches, with a recent review providing more insights on this issue [38]. Overall, our own view is to encourage the use of threshold zones to set intensity if CPET is available.
Training improves aerobic capacity (VO2 peak)
Aerobic training protocols vary in their description of exercise intensity, training volume, and exercise modality. For consistency, we used the ACSM classification (Table 1) to categorize training zones rather than the classification reported in each publication by aligning the measures reported (e.g., HRR, HRmax, VO2peak) with the relevant training zone. Aerobic protocols are grouped into continuous and interval training and a full description of all aerobic training protocols is presented in Table 2.
Continuous training protocols
Continuous aerobic training, defined as continuous exercise without active or passive recovery is the most common type of protocol for PD, with studies reporting a wide variation in both intensity and volume. Both moderate and vigorous intensities yield improvements in VO2peak, however, to optimise outcome it may be necessary to reach a minimum volume of training such as that described by the ACSM (150 min of moderate or 75 min of vigorous aerobic training per week) [4].
Schenkman et al. [39], reported no significant improvement in VO2peak in 45 PD participants after exercising 3–4 times per week for 30 min per session for 26 weeks, at an average intensity of 65.9% HRmax (moderate training zone – ACSM). Conversely, Shulman et al., [22] reported an improvement of around 6% in VO2peak in 22 PD participants exercising at 40–50% HRR (moderate training zone -ACSM) in a training protocol that incorporated a comparatively higher weekly volume of training (50 min per session, 3 × per week for 12 weeks).
Gains in aerobic capacity from vigorous intensity protocols (77–95% HRmax/60–89% HRR—ACSM) also vary considerably in people with PD. Participants from a study by Sacheli et al., [41] improved their VO2peak by approximately 22%, while participants from Shulman et al., [22] who also exercise at a vigorous intensity zone, improved their VO2peak on average of 7%, despite participants having similar baseline VO2peak values. The difference in aerobic fitness findings between these two studies may be due to the way in which exercise intensity and training volume were prescribed [18, 38, 48].
The protocol from Sacheli et al., [41] consisted of 3 sessions of bike training (30–50 min) per week for 12 weeks, with participants exercising at a workload relative to 60–80% VO2peak attained during CPET, representing moderate to vigorous training zone (Table 1). Exercise intensity and duration were increased after every third session. The total volume of training was high (90–150 min of exercise) at the target intensity. Participants from Shulman et al., [22] had the same length of training as Sacheli et al., [41] (3 × per week for 12 weeks), but exercised at a lower training volume. Exercise duration increased progressively from 15 to 30 min by 5 min every two weeks. Exercise intensity also increased progressively (from 40–50% HRR to 70–80% HRR) by adjusting treadmill speed and inclination. The total volume of training from this protocol varied from 45 to 90 min of exercise, but it is unclear whether training volume was targeted to intensity.
Taken together, these studies suggest that vigorous-intensity aerobic protocols potentially promote greater improvement in VO2peak compared with moderate-intensity protocols, but differences in the volume of training at the target exercise intensity will also impact this.
Interval training protocols
The ability to exercise continuously for a long period of time at high intensities is limited [3, 18]. Interval training protocols intersperse a work phase of moderate or high intensity with a recovery phase of lower intensity or passive recovery to offset this. Moderate-intensity interval training (MIIT) uses bursts of moderate-intensity whilst high-intensity interval training (HIIT) uses bursts of high intensity during the ‘work phase’ of the training protocol [4, 25, 49]. MIIT is better tolerated for beginners and used as a progression to HIIT protocols if required [49], bearing in mind that longer durations of the work phase are required to produce a training effect. A recent study that applied an MIIT protocol in 13 sedentary PD participants reported a 30.49% increase in VO2peak after 8 weeks exercising 3 × per week using an arm crank ergometer [47]. The 60-min MIIT protocol consisted of 4 × of 10 min of arm cycling at workload relative to 50–70% VO2peak interspersed by 4 min of recovery (total volume of 120 min). However, the study did not include a control group and the increase in VO2peak may reflect a learning effect [50].
HIIT requires lower training volumes compared with continuous protocols for comparable gains in aerobic capacity [51]. To date, the optimal training volume and the ideal time frames for the work and recovery phases for HIIT protocols have not yet been defined for PD. Recent evidence from general and selected clinical populations suggests that work phases should be 2 to 4 min and a total time in high-intensity zone should be at least 15 min per session in order to maximize gains in aerobic capacity, but even shorter durations have been found to enhance fitness levels [26, 35, 52, 53]. HIIT protocols are not commonly used in PD, with only a few studies investigating their potential effect on aerobic capacity in this population [20, 40, 43].
Harvey et al., [43] examined the feasibility of a HIIT protocol using resistance machines in 16 PD participants whose VO2peak improved about 9% after 12 weeks of aerobic training. The protocol consisted of 3 weekly sessions of 4 × of 4 min ‘work phase’ (split in 45 s of exercising and 15 s to change from one machine to another) and 3.5 min of recovery. Over 80% of exercise repetitions were ≥ 85% HRmax, thus meeting the broad recommendation for high-intensity training. The total volume involved 36 min (12 min per session) of aerobic training (at high-intensity zone) per week, which is significantly lower compared to other protocols in PD. Demonceau et al., [20] reported a comparable level of improvement of 12% in VO2peak in 16 PD participants also after 12 weeks (2–3 sessions per week) of training using a mixed-protocol (continuous + HIIT). The first four weeks included continuous training at 50% of peak workload (WRpeak), obtained from CPET, for 30–45 min (2 × per week). From the fifth week, at least one session of interval training (‘work phase’ of 30 s to 3 min at 70–80% WRpeak and active recovery of 30–90 s at 50% WRpeak) was added until the end of the 12-week protocol. These studies suggest HIIT protocols have the potential to increase VO2peak in people with PD. However, a combination of continuous with HIIT protocols may be more beneficial.
On the whole, studies that incorporate HIIT protocols for people with PD appear to be well tolerated and feasible [20, 43] although this is not a universal finding. Uc et al., [40] withdrew participants from their HIIT protocol due to a higher risk of injury and lack of significant improvement in VO2peak compared to participants exercising continuously (2.0 ± 3.5 and 1.1 ± 2.7 mL/min/kg, respectively). Participants in the HIIT protocol were instructed to exercise at 80–90% HRmax interspersed by 60–70% HRmax, while those in the continuous group at 70–80% HRmax [40]. The authors from this study used age-predicted Eqs. (220-age) to calculate HRmax. Although both groups exercised at comparable mean HRmax (69.2% HRmax and 71.1% Hrmax, respectively), the mean HR attained at bouts of high intensity was not reported [40], which may have influenced the outcome.
Overall, research to date suggests that aerobic training using moderate to vigorous intensity protocols (per ACSM classification) produce gains in aerobic capacity in PD. Aerobic training protocols with a high volume of training in combination with vigorous to higher exercise intensities appear to elicit greater improvement in aerobic capacity compared with low-volume training at moderate intensities. However, the results need to be interpreted with some caution given the possible presence of CI, as shown in other clinical populations and our work, which may influence VO2peak [54, 55]. Also, the protocols we review here do not use threshold training zones (e.g., VT1 and VT2) to inform training regimes, which we consider to be more accurate and individualised. Moreover, gender, age, baseline fitness level, and genetic factors may also contribute to lack of improvement in VO2peak [4, 56].
Volume of training mediates improvement in motor function
Aerobic training protocols that adhere to principles of exercise intensity also report improvements in functional performance in PD (Table 3). Shulman et al., [22] reported an improvement of 12% in distance walked in the 6-min walking test (6MWT) for 22 PD participants after exercising on the treadmill at 40–50% HRR (moderate training zone—ACSM) for 150 min per week for 12 weeks. By contrast, participants exercising on the treadmill at 70–80% HRR (vigorous training zone—ACSM) for 90 min per week improved their 6MWT distance by only 6% [22]. Both groups showed a similar improvement in aerobic capacity (8% and 7%, respectively). These results suggest that training volume has a greater impact on function than intensity. Similarly, several studies report a significant improvement in VO2peak after training at moderate to vigorous intensities without concomitant improvements in 6MWT and timed up and go (TUG) scores [20, 21, 41]. This may reflect a lack of training specificity given that all studies used cycle ergometer, although it is not a consistent finding. Dag et al. [47] reported significant improvement in functional outcomes (6MWT and TUG) in PD after 8 weeks of aerobic training using an arm crank ergometer. The authors suggested that the interlimb connection, which is necessary during walking, was prompted during upper limbs exercises explaining significant gains in lower body functional performance [47].
Moderate and vigorous training improves motor symptoms
Training at moderate to vigorous intensity may also improve motor symptoms in mild to moderate PD. Schenkman et al. [39] reported a significantly lower change in the Unified Parkinson's Disease Rating Scale motor scores (UPDRS III) suggesting motor stability and therefore less disease progression, rather than worsening of symptoms after 6 months of 30 min on a treadmill (4 × per week) at a higher intensity (mean 80.2% HRmax), compared with participants who trained at lower intensities (mean 65.9% HRmax). van der Kolk et al. [21] reported comparable findings on UPDRS III scores in favour of aerobic continuous training in participants who trained for 24 weeks at an average of 76.4% HRmax on a stationary bike. Dag et al. [47] also reported significant improvement in the UPDRS III (on-state) after 8 weeks of moderate interval intensity training. By contrast, Sacheli et al., [41] reported no change in UPDRS III (off-state) scores or cognitive test scores in 20 PD participants after 12 weeks exercising at moderate to vigorous intensity (60–80% VO2peak). The authors interpreted these findings as due possibly to measurement limitations or to a reverse causation effect (PD patients with better dopaminergic function are more likely to exercise). Despite this result, a tentative conclusion overall is that training at moderate to vigorous intensity rather than high intensity is sufficient to effect an improvement in motor symptoms and to stabilise symptoms over 6 months [21, 39, 47].
Is aerobic training neuroprotective?
Two recent studies using neuroimaging techniques and transcranial magnetic stimulation, revealed cortical and subcortical change in response to aerobic exercise, providing emergent evidence for exercise-induced neuroplasticity in PD [8, 41]. In a sub-group of participants from van der Kolk’s study (n = 57), Johansson et al. [8] reported an increase in functional connectivity of cortical and subcortical structures, whilst Sacheli et al. [41] reported an increase in ventral striatum activity in 35 participants and enhanced dopamine release in the caudate nucleus in 25 participants. In line with the studies discussed above, participants in both of these sub-groups also exercised at moderate to vigorous intensity. Recent reviews provide more detail on this topic [57] as well as ongoing studies such as SPARX3 [9] aim to examine the mechanisms underpinning symptom stability following particularly high-intensity aerobic training.
Aerobic training protocols: current recommendations
Table 4 summarises the current guidelines for aerobic training in PD which overall recommend continuous training protocols at (predominantly) vigorous intensity. The ACSM guideline includes a progressive increase in exercise intensity based on the level of fitness and disease severity. The suggestion includes 30 min of continuous or accumulated aerobic exercise at intensities varying from 60 to 65% (more advanced PD) to 80–85% HRmax (mild to moderate PD) with the aim of improving aerobic capacity and modifying disease progression. [4]. In addition to a progressive increase in exercise intensity based on the level of fitness, Kim et al. [58] suggest a progressive rise in training volume from 20 to 60 min, while Martignon et al. [59] propose altering training volume and exercise intensity as the disease progresses. The recommendation from Albert et al., [10] does not highlight a progressive increase in training intensity and volume but recommend using RPE to monitor exercise intensity if autonomic dysfunction (CI) is presented. However, given its subjectivity, in such cases the RPE may be better suited as an adjunct to more accurate measures of aerobic intensity [60].
While HIIT is feasible and shows potential for improving aerobic capacity in individuals with PD [20, 43], it is not included in these recommendations. Training based on the threshold zones is also not recommended, possibly because of the need for expensive equipment (CPET) and because viable alternative such as %HRmax or %HRR exists. The guidelines for PD do not present specific exercise intensity parameters or volume of training for enhancing aerobic capacity, functional performance, or symptoms related to PD. Additionally, there is no indication of the most suitable exercise modality for achieving these outcomes. In general, the optimal frequency, intensity, time, type, volume, and progression, the so-called FITT-VP principle of training [61], are unclear for people with PD.
Autonomic disturbance affects response to exercise
The method for calculating training intensity may also influence exercise safety and training outcomes for people with PD, particularly for those with autonomic disturbance. A common feature of autonomic dysfunction is chronotropic incompetence (CI), defined as the inability to raise HR (usually up to a threshold of 85% age-predicted HRmax) in proportion to the increased exercise demand despite physiological and clinical measures indicating that maximal effort has occurred [62, 63]. Other features of the autonomic nervous system, such as heart contractility and fatigue, impacting aerobic capacity and exercise programming in PD, is beyond the focus of this narrative review [64, 65].
The estimated prevalence of CI in PD is 40–50% and its effect on response to exercise is gaining interest [44, 66]. Penko et al., [44] reported that 60/100 (40%) of participants with CI were unable to achieve 85% of their age-predicted HRmax during CPET, while Kanegusuku et al., [67] reported that only 35.4% and 8.3% achieved 90% and 100%, respectively, of their age-predicted HRmax. In PD, CI is most likely due to dysfunction of the sympathetic innervation [66, 68], and is difficult to detect at rest and during low-intensity exercise [67]. Traditional equations using age-predicted HRmax (e.g., 220-age) can be inaccurate at determining training intensity in PD with CI, even when using the HRR equation because resting HR measures are often comparable to normal values [67,68,69,70].
Unpublished CPET data from our laboratory reveal that physically active individuals with PD with CI had a mean HRmax that was approximately 30 beats per minute below their age-predicted HRmax and although they exercised at high intensity (based on CPET threshold zones) it was at a much lower absolute HR compared to participants without CI (Fig. 1). A similar outcome is seen if general training guidelines are used for aerobic exercise prescription in this population (Fig. 2). These results highlight the inaccuracy of age-predicted equations, underestimating training zone for people with PD with CI, and the needs of using individualized measures for determining exercise intensity if data from CPET is available.
PD medication and aerobic training
As the mainstay of symptom management in PD, dopaminergic replacement does not appear to influence HR responses or measurement of VO2peak [68]. Testing and measurement procedures are commonly carried out in the ‘on’ state (usually 1 h after the medication), but advice for training sessions is less evident. There is a general rule that exercising ‘on’ is optimal, with some people administering an extra dose to boost the ‘on’ state during exercise [11]. However, it is unclear whether the timing of medication has a beneficial or deleterious effect on gains in aerobic capacity.
Conclusion
Whilst there is a positive effect of intensity on aerobic performance (VO2peak) in PD, its influence on motor symptoms and function is less clear. The emphasis on intensity during training has potentially devalued the role of volume and exercise modality in influencing these outcomes. Comprehensive reporting of training protocols is required to optimise outcome, whilst acknowledging the limits of predicted equations to determine training zones and response to training. Lastly, further research is required to understand the marked effect of CI on aerobic performance and the need to identify this sub-group within a study population.
Data Availability
No datasets were generated or analysed during the current study.
Abbreviations
- PD:
-
Parkinson’s disease
- UPDRS:
-
Unified Parkinson's disease rating scale
- CI:
-
Chronotropic incompetence
- CPET:
-
Cardiopulmonary exercise testing
- HR:
-
Heart rate
- HRmax:
-
Maximum heart rate
- HRR:
-
Heart rate reserve
- VO2peak:
-
Peak oxygen consumption
- VT1:
-
First ventilatory threshold
- VT2:
-
Second ventilatory threshold
- WR peak:
-
Peak workload
- RPE:
-
Rating of perceived exertion
- MIIT:
-
Moderate interval intensity training
- HIIT:
-
High intensity interval training
- 6MWT:
-
6-Minutes walking test
- TUG:
-
Timed up and go
- ACSM:
-
American College of Sports Medicine
References
Cheng YC, Su CH (2020) Evidence supports PA prescription for parkinson’s disease: Motor symptoms and non-motor features: a scoping review. Int J Environ 17(8):2894
Ellis T, Rochester L (2018) Mobilizing Parkinson’s disease: the future of exercise. J Parkinsons Dis 8(s1):S95–S100
McArdle WD, Exercise physiology : nutrition, energy, and human performance. Eighth edition. ed. 2015, Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins
Liguori G et al., ACSM's guidelines for exercise testing and prescription. Eleventh edition. ed, ed. G. Liguori, et al. 2022, Philadelphia: Wolters Kluwer
Zhen K et al (2022) A systematic review and meta-analysis on effects of aerobic exercise in people with Parkinson’s disease. NPJ Parkinsons Dis 8(1):146
Schootemeijer S, Darweesh SKL, de Vries NM (2022) Clinical trial highlights - aerobic exercise for Parkinson’s disease. J Parkinsons Dis 12(8):2297–2306
Ahlskog JE (2018) Aerobic exercise: evidence for a direct brain effect to slow parkinson disease progression. Mayo Clin Proc 93(3):360–372
Johansson ME et al (2022) Aerobic exercise alters brain function and structure in Parkinson’s disease: a randomized controlled trial. Ann Neurol 91(2):203–216
Patterson CG et al (2022) Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials 23(1):855
Alberts JL, Rosenfeldt AB (2020) The universal prescription for Parkinson’s disease: exercise. J Parkinsons Dis 10(s1):S21–S27
Schootemeijer S et al (2020) Current perspectives on aerobic exercise in people with Parkinson’s disease. Neurotherapeutics 17(4):1418–1433
Aburub A et al (2020) Cardiopulmonary function and aerobic exercise in parkinson’s: a systematic review of the literature. Mov Disord Clin Pract 7(6):599–606
Gamborg M et al (2022) Parkinson’s disease and intensive exercise therapy - An updated systematic review and meta-analysis. Acta Neurol Scand. https://doi.org/10.1111/ane.13579
Cui W et al (2023) The effects of exercise dose on patients with Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials. J Neurol. https://doi.org/10.1007/s00415-023-11887-9
Wolpern AE et al (2015) Is a threshold-based model a superior method to the relative percent concept for establishing individual exercise intensity? a randomized controlled trial. BMC Sports Sci Med Rehabil 7:16
De Pablo-Fernandez E et al (2017) Association of autonomic dysfunction with disease progression and survival in parkinson disease. JAMA Neurol 74(8):970–976
Goncalves VC et al (2021) Heart matters: cardiac dysfunction and other autonomic changes in Parkinson’s disease. Neuroscientist 28(6):530–542
Laursen P, Buchheit M (2019) Science and application of high-intensity interval training : solutions to the programming puzzle. Human Kinet. https://doi.org/10.5040/9781492595830
Wasserman, K., Principles of exercise testing and interpretation : including pathophysiology and clinical applications. Fifth edition. ed. 2012: Wolters Kluwer Health/Lippincott Williams & Wilkins
Demonceau M et al (2017) Effects of twelve weeks of aerobic or strength training in addition to standard care in Parkinson’s disease: a controlled study. Eur J Phys Rehabil Med 53(2):184–200
van der Kolk NM et al (2019) Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson’s disease: a double-blind, randomised controlled trial. Lancet Neurol 18(11):998–1008
Shulman LM et al (2013) Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol 70(2):183–190
Norton K, Norton L, Sadgrove D (2010) Position statement on physical activity and exercise intensity terminology. J Sci Med Sport 13(5):496–502
StØren Ø et al (2017) The effect of age on the v–o2max response to high-intensity interval training. Med Sci Sports Exerc 49(1):78–85
Guiraud T et al (2012) High-intensity interval training in cardiac rehabilitation. Sports Med 42(7):587–605
Wen D et al (2019) Effects of different protocols of high intensity interval training for VO2max improvements in adults: a meta-analysis of randomised controlled trials. J Sci Med Sport 22(8):941–947
Davos CH (2019) Do we have to reconsider the guidelines for exercise intensity determination in cardiovascular rehabilitation? Eur J Prev Cardiol 26(18):1918–1920
Hansen D et al (2019) Exercise training intensity determination in cardiovascular rehabilitation: should the guidelines be reconsidered? Eur J Prev Cardiol 26(18):1921–1928
Seiler S (2010) What is best practice for training intensity and duration distribution in endurance athletes? Int J Sports Physiol Perform 5(33):276–291
Suarez VJC, Gonzalez-Rave JM (2014) Four weeks of training with different aerobic workload distributions–effect on aerobic performance. Eur J Sport Sci 14(Suppl 1):S1-7
Foster C et al (2005) Regulation of energy expenditure during prolonged athletic competition. Med Sci Sports Exerc 37(4):670–675
Wahl P, Bloch W, Proschinger S (2022) The molecular signature of high-intensity training in the human body. Int J Sports Med 43(3):195–205
Weatherwax RM et al (2019) Incidence of VO2max responders to personalized versus standardized exercise prescription. Med Sci Sports Exerc 51(4):681–691
Fabre C et al (1997) Effectiveness of individualized aerobic training at the ventilatory threshold in the elderly. J Gerontol A Biol Sci Med Sci 52(5):B260–B266
Lehtonen E et al (2022) Hierarchical framework to improve individualised exercise prescription in adults: a critical review. BMJ Open Sport Exerc Med 8(2):e001339
Bourgois JG, Bourgois G, Boone J (2019) Perspectives and determinants for training-intensity distribution in elite endurance athletes. Int J Sports Physiol Perform 14(8):1151–1156
Pymer S et al (2020) Does exercise prescription based on estimated heart rate training zones exceed the ventilatory anaerobic threshold in patients with coronary heart disease undergoing usual-care cardiovascular rehabilitation? a United Kingdom perspective. Eur J Prev Cardiol 27(6):579–589
Jamnick NA et al (2020) An examination and critique of current methods to determine exercise intensity. Sports Med 50(10):1729–1756
Schenkman M et al (2017) Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol 75(2):219–226
Uc EY et al (2014) Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting. Neurology 83(5):413–425
Sacheli MA et al (2019) Exercise increases caudate dopamine release and ventral striatal activation in Parkinson’s disease. J Mov Disord 34(12):1891–1900
Kurtais Y et al (2008) Does treadmill training improve lower-extremity tasks in Parkinson disease? a randomized controlled trial. Clin J Sport Med 18(3):289–291
Harvey M et al (2019) High-intensity interval training in people with Parkinson’s disease: a randomized, controlled feasibility trial. Clin Rehabil 33(3):428–438
Penko AL et al (2021) The impact of aerobic exercise on cardiopulmonary responses and predictors of change in individuals with Parkinson’s disease. Arch Phys Med Rehabil 102:925–931
Mavrommati F et al (2017) Exercise response in Parkinson’s disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trial. BMJ Open 7:e017194
Collett J et al (2017) Phase II randomised controlled trial of a 6-month self-managed community exercise programme for people with Parkinson’s disease. J Neurol Neurosurg Psychiatry 88(3):204–211
Dag F, Cimen OB, Dogu O (2021) The effects of arm crank training on aerobic capacity, physical performance, quality of life, and health-related disability in patients with Parkinson’s disease. Ir J Med Sci 191:1341–1348
Moholdt T et al (2014) The higher the better? interval training intensity in coronary heart disease. J Sci Med Sport 17(5):506–510
Jimenez-Pavon D, Lavie CJ (2017) High-intensity intermittent training versus moderate-intensity intermittent training: is it a matter of intensity or intermittent efforts? Br J Sports Med 51(18):1319–1320
Katzel LI et al (2011) Repeatability of aerobic capacity measurements in Parkinson’s disease. Med Sci Sports Exerc 43(12):2381–2387
Batacan RB Jr et al (2017) Effects of high-intensity interval training on cardiometabolic health: a systematic review and meta-analysis of intervention studies. Br J Sports Med 51(6):494–503
Taylor JL et al (2019) Guidelines for the delivery and monitoring of high intensity interval training in clinical populations. Prog Cardiovasc Dis 62(2):140–146
Quindry JC et al (2019) Benefits and risks of high-intensity interval training in patients with coronary artery disease. Am J Cardiol 123(8):1370–1377
Smarz K et al (2021) Chronotropic incompetence limits aerobic exercise capacity in patients taking beta-blockers: real-life observation of consecutive patients. Healthcare (Basel) 9(2):212
Herbsleb M et al (2019) The influence of continuous exercising on chronotropic incompetence in multi-episode schizophrenia. Front Psychiatry 10:90
Meyler S, Bottoms L, Muniz-Pumares D (2021) Biological and methodological factors affecting V O 2 max response variability to endurance training and the influence of exercise intensity prescription. Exp Physiol 106(7):1410–1424
Johansson H et al (2020) Exercise-induced neuroplasticity in parkinson’s disease: a metasynthesis of the literature. Neural Plast 2020:8961493
Kim Y et al (2019) Exercise training guidelines for multiple sclerosis, stroke, and Parkinson disease: rapid review and synthesis. Am J Phys Med Rehabil 98(7):613–621
Martignon C et al (2021) Guidelines on exercise testing and prescription for patients at different stages of Parkinson’s disease. Aging Clin Exp Res 33(2):221–246
Hansen D et al (2022) Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol 29(1):230–245
Bushman BA (2018) Developing the P (for progression) in a FITT-VP exercise prescription. ACSM’s Health Fit J 22(3):6–9
Brubaker PH et al (2006) Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J Cardiopulm Rehabil Prev 26(2):86–89
Brubaker PH, Kitzman DW (2011) Chronotropic incompetence: causes, consequences, and management. Circulation 123(9):1010–1020
Pechstein AE, Gollie JM, Guccione AA (2020) Fatigability and cardiorespiratory impairments in Parkinson’s disease: potential non-motor barriers to activity performance. J Funct Morphol Kinesiol 5(4):78
Nakamura T et al (2010) Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson’s disease. Mov Disord 25(9):1183–1189
Speelman AD et al (2012) Cardiovascular responses during a submaximal exercise test in patients with Parkinson’s disease. J Parkinsons Dis 2(3):241–247
Kanegusuku H et al (2016) Blunted maximal and submaximal responses to cardiopulmonary exercise tests in patients with Parkinson disease. Arch Phys Med Rehabil 97(5):720–725
DiFrancisco-Donoghue J et al (2009) Norepinephrine and cardiovascular responses to maximal exercise in Parkinson’s disease on and off medication. J Mov Disord 24(12):1773–1778
Miyasato RS et al (2018) Cardiovascular responses during resistance exercise in patients with Parkinson disease. Am Acad Phys Med Rehabil 10:1145–1152
Werner WG, Lamberg EM (2006) Cardiovascular response to treadmill testing in Parkinson disease. J Neurol Phys Ther 30(2):68–73
Acknowledgements
This study was funded in part by the Neurology Special Interest Group of Physiotherapy New Zealand Award (NSIG) and Parkinson’s New Zealand (PNZ). Funding sources did not impact the content of this review. The authors declare that there are no conflicts of interest for this review.
Funding
Open Access funding enabled and organized by CAUL and its Member Institutions.
Author information
Authors and Affiliations
Contributions
All authors contributed to defining the scope and objectives of the review. Author Tone P conducted a thorough review of existing literature, drafted the manuscript, and created figures and tables. Authors Sue L and Grant M played a key role on editing and revising the content. Author Denise T review of the final draft.
Corresponding author
Ethics declarations
Confict of interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Panassollo, T.R.B., Mawston, G., Taylor, D. et al. Targeting exercise intensity and aerobic training to improve outcomes in Parkinson’s disease. Sport Sci Health 20, 287–297 (2024). https://doi.org/10.1007/s11332-024-01165-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11332-024-01165-0